![Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016 Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016](https://www.sec.gov/Archives/edgar/data/818686/000119312516706460/g257842ex99_1s13g1.jpg)
Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016
![Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016 Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016](https://www.sec.gov/Archives/edgar/data/818686/000119312516706460/g257842ex99_1s18g1.jpg)
Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016
![Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016 Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016](https://www.sec.gov/Archives/edgar/data/818686/000119312516706460/g257842ex99_1s44g1.jpg)
Teva Pharmaceutical Industries 6-K (Current Report of Foreign Issuer) - TEVA PHARMACEUTICAL INDUSTRIES LTD - 6-K - September 09, 2016
![CSRWire - Teva Continues to Advance Care for Society's Health and Wellbeing; 2016 Social Impact Report Released CSRWire - Teva Continues to Advance Care for Society's Health and Wellbeing; 2016 Social Impact Report Released](https://back.3blmedia.com/sites/default/files/styles/desktop_main_3_2/public/client_content/original_csrwire/2017-09-14_9-00-59.jpg)
CSRWire - Teva Continues to Advance Care for Society's Health and Wellbeing; 2016 Social Impact Report Released
![EX-99.1 2 a17-11998_4ex99d1.htm EX-99.1 Exhibit 99.1 2016 ANNUAL REPORT EAGLE PHARMACEUTICALS, INC. (Nasdaq: EGRX) Eagle Pharmaceuticals 2016 and Q1 2017 Key Accomplishments: • Bendeka®1 granted unique J-code, triggering ... EX-99.1 2 a17-11998_4ex99d1.htm EX-99.1 Exhibit 99.1 2016 ANNUAL REPORT EAGLE PHARMACEUTICALS, INC. (Nasdaq: EGRX) Eagle Pharmaceuticals 2016 and Q1 2017 Key Accomplishments: • Bendeka®1 granted unique J-code, triggering ...](https://www.sec.gov/Archives/edgar/data/827871/000110465917027952/g119984mm03i001.jpg)